Siemens to sell microbiology unit to U.S.-based Danaher
FRANKFURT (Reuters) - German engineering group Siemens agreed to sell its clinical microbiology business to Beckman Coulter [DHRBE.UL], a subsidiary of Danaher Corp, as part of a restructuring plan designed to improve profitability.
Siemens, which did not disclose financial details of the deal, said the move allowed it to focus its healthcare division more on its in-vitro business.
The transaction is expected to close in the first quarter of 2015 and is subject to regulatory approvals, Beckman Coulter said in a statement.
(Reporting by Thomas Atkins; Editing by Prateek Chatterjee)